Pfizer and BioNTech seek green light for tweaked Covid-19 vaccine that targets Omicron subvariants
The shot, which targets latest Omicron subvariants as well as the original virus, would be used in fall booster campaign
Since the start of the Covid-19 pandemic in 2020, the scientific understanding of its transmission and prevention has evolved. WSJ’s Daniela Hernandez explains what strategies have worked for stemming the spread of the virus and which are outdated in 2022. Illustration: Adele MorganPfizer Inc. and BioNTech SE have asked U.S.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives
Read more »
Pfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Read more »
2 pop-up clinics offering vaccines for COVID-19, monkeypox SaturdayTwo vaccine clinics are taking place to protect people against both COVID-19 and monkeypox.
Read more »